AU2003300957A1 - Anti-infectives - Google Patents

Anti-infectives

Info

Publication number
AU2003300957A1
AU2003300957A1 AU2003300957A AU2003300957A AU2003300957A1 AU 2003300957 A1 AU2003300957 A1 AU 2003300957A1 AU 2003300957 A AU2003300957 A AU 2003300957A AU 2003300957 A AU2003300957 A AU 2003300957A AU 2003300957 A1 AU2003300957 A1 AU 2003300957A1
Authority
AU
Australia
Prior art keywords
infectives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300957A
Other versions
AU2003300957A8 (en
Inventor
Deping Chai
Kevin J. Duffy
Duke M. Fitch
Antony N. Shaw
Rosanna Tedesco
Kenneth J. Wiggall
Michael N. Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2003300957A1 publication Critical patent/AU2003300957A1/en
Publication of AU2003300957A8 publication Critical patent/AU2003300957A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003300957A 2002-12-11 2003-12-11 Anti-infectives Abandoned AU2003300957A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43246202P 2002-12-11 2002-12-11
US60/432,462 2002-12-11
PCT/US2003/039983 WO2004052313A2 (en) 2002-12-11 2003-12-11 Anti-infectives

Publications (2)

Publication Number Publication Date
AU2003300957A1 true AU2003300957A1 (en) 2004-06-30
AU2003300957A8 AU2003300957A8 (en) 2004-06-30

Family

ID=32507933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300957A Abandoned AU2003300957A1 (en) 2002-12-11 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003300957A1 (en)
WO (1) WO2004052313A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1786807B1 (en) 2004-08-23 2009-07-29 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
RU2388748C2 (en) 2004-12-21 2010-05-10 Ф. Хоффманн-Ля Рош Аг Tetralin and indane derivatives and use thereof as 5-ht antagonists
CN101189230A (en) 2005-05-04 2008-05-28 弗·哈夫曼-拉罗切有限公司 Heterocyclic antiviral compounds
CN101300246A (en) 2005-11-03 2008-11-05 弗·哈夫曼-拉罗切有限公司 Arylsulfonylchromans as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
DE602007011213D1 (en) 2006-02-17 2011-01-27 Hoffmann La Roche HETEROCYCLIC ANTIVIRAL COMPOUNDS
EP2361922B1 (en) 2006-10-10 2012-08-22 Janssen Products, L.P. Intermediate to HCV-Nucleoside Inhibitors
JP2012519661A (en) 2009-03-06 2012-08-30 エフ.ホフマン−ラ ロシュ アーゲー Antiviral heterocyclic compounds
KR20120011880A (en) 2009-04-25 2012-02-08 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds
EP2445875A2 (en) 2009-06-24 2012-05-02 F. Hoffmann-La Roche AG Heterocyclic antiviral compound
MX2012003170A (en) 2009-09-21 2012-04-11 Hoffmann La Roche Heterocyclic antiviral compounds.
MX2012005528A (en) 2009-11-14 2012-06-12 Hoffmann La Roche Biomarkers for predicting rapid response to hcv treatment.
CA2778206A1 (en) 2009-11-21 2011-05-26 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
RU2012127201A (en) 2009-12-02 2014-01-20 Ф.Хоффманн-Ля Рош Аг BIOMARKERS FOR FORECASTING A SUSTAINABLE RESPONSE TO THE TREATMENT OF HEPATITIS C VIRUS
GB201102659D0 (en) 2011-02-15 2011-03-30 Isis Innovation Assay
GB201113101D0 (en) 2011-07-28 2011-09-14 Isis Innovation Assay
RU2534613C2 (en) 2013-03-22 2014-11-27 Александр Васильевич Иващенко Alkyl2-{[(2r,3s,5r)-5-(4-amino-2-oxo-2h-pyrimidine-1-yl)- -hydroxy- tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-proptonates, nucleoside inhibitors of rna-polymerase hcv ns5b, methods for producing and using them
CN105294648B (en) * 2015-11-30 2017-11-28 山东罗欣药业集团股份有限公司 A kind of preparation method of sitafloxacin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034041A1 (en) * 2000-05-10 2004-02-19 Dashyant Dhanak Novel anti-infectives

Also Published As

Publication number Publication date
WO2004052313A2 (en) 2004-06-24
WO2004052313A3 (en) 2004-09-02
AU2003300957A8 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003248566A1 (en) Novel anti-infectives
AU2003297235A1 (en) Anti-infectives
AU2003300957A1 (en) Anti-infectives
AU2003300956A1 (en) Anti-infectives
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2002344387A1 (en) Multifunction-pillow
AU2002100280A4 (en) Proshoe
AU2002100739A4 (en) Neuramax
AU2002100160A4 (en) Oxidirator
AU2002100031A4 (en) earliPay
AU2002100026A4 (en) Disc400
AU2002100482A4 (en) Tail-gate-ezy
AU2002100655A4 (en) Armamulch
AU2002100468A4 (en) Flexi-edger
AU2002100747A4 (en) Powersell
AU2002100602A4 (en) Bonsystem
AU2002100498A4 (en) Linline
AU2002100508A4 (en) Photocard
AU2002100510A4 (en) Bottlenecker
AU2002100541A4 (en) Backmate

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase